Clinical & pathological characteristics | No. |
---|---|
Mean (s.d.) Age (years) | 66 (±12) |
Sex | |
Male | 68 (58) |
Female | 49 (42) |
Mean (s.d.) follow-up (months) | 57 (±25) |
Median follow-up (range) | 61 (5-113) |
Tumor stage | |
T1 | 3 (2) |
T2 | 9 (8) |
T3 | 82 (69) |
T4 | 13 (11) |
Node stage | |
N0 | 78 (67) |
N1 | 39 (33) |
Mean (s.d.) number of LN harvested | 27,5 (±14) |
Microsatellite instability status | |
Positive | 10 (9) |
Negative | 107 (91) |
Number of CD3+ lymphocytes/mm² (TMA) | |
Mean | 612 (±481) |
Range | 21-3014 |